Interestingly, AG1024 concentration of 10 and 50 μM are more effective on CML cells than on normal CD34 cells, suggesting the existence of a differential effect of Tyrphostin AG1024 (Figure 7). This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.